参考文献

1.National Lung Screening Trial Research Team，Aberle DR，Berg CD，et al.The National Lung Screening Trial： overview and study design.Radiology， 2011， 258（1）： 243-253.

2.National Lung Screening Trial Research Team，Aberle DR，Adams AM，et al.Reduced lungcancer mortality with low-dose computed tomographic screening.N Engl J Med， 2011， 365（5）： 395-409.

3.National Lung Screening Trial Research Team，Aberle DR，Adams AM，et al.Baseline characteristics of participants in the randomized national lung screening trial.J Natl Cancer Inst，2010， 102（23）： 1771-1779.

4.Wu Y， Li P， Zhang H， et al.Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.Int J Cancer， 2013， 132（2）： E37-E47.

5.Carney DN.Lung cancer--time to move on from chemotherapy.N Engl J Med， 2002， 346（2）： 126-128.

6.Chute JP，Chen T，Feigal E，et al.Twenty years of phaseⅢtrials for patients with extensivestage small-cell lung cancer： perceptible progress.J Clin Oncol， 1999， 17（6）： 1794-1801.